Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 606

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 6
Chunk 606
---
2024, the Company effected a one-for-eight reverse stock split of its common stock
                                            (the “Reverse Stock Split”) with the Company’s shares beginning trading
                                            on a post-split basis on the Nasdaq Capital Market on April 23, 2024. Upon the effectiveness
                                            of the Reverse Stock Split, every eight shares of the Company’s issued and outstanding
                                            common stock was automatically converted into one share of common stock, without any change
                                            in the par value per share. In addition, a proportionate adjustment was made to the per share
                                            exercise price and the number of shares issuable upon the exercise of all outstanding options
                                            and warrants entitling the holders to purchase common stock. Any fraction of a share of common
                                            stock that would otherwise have resulted from the Reverse Stock Split was rounded up to the
                                            next whole number. All the per-share data was adjusted to
give retroactive effect of 1:8 reverse stock split effected in April 2024.

    c.
    On
    August 24, 2023, the Company entered into an inducement offer letter agreement (the “2023 Inducement Letter”) with a
    certain holder of certain of the Company’s existing warrants to purchase up to (i) 1,963,994
    shares of the Company’s common stock issued on January 12, 2023 at an exercise price of $2.805
    per share (the “January 2023 Warrants”), (ii) 6,864
    shares of the Company’s common stock issued on January 17, 2020 at an exercise price of $94.00
    per share (the “January 2020 Warrants”), and (ii) 47,153
    shares of the Company’s common stock issued on October 28, 2021 at an exercise price of $31.50
    per share, having terms ranging from 28 months to five and one-half years (the “October 2021 Warrants” and together with
    the January 2023 Warrants and the January 2020 Warrants, the “2023 Existing Warrants). Pursuant to the 2023 Inducement Letter,
    the holder agreed to exercise for cash its 2023 Existing Warrants to purchase an aggregate of 2,018,012
    shares of the Company’s common stock at a reduced exercise price of $2.09
    per share in